Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital

Abstract This study aimed to identify, based on available literature, the risk factors for adverse events during transport and hyperbaric oxygen therapy (HBOT) sessions in intensive care unit patients and to determine their impact on intra-ward mortality and hospitalization duration. A retrospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Aneta Miszewska, Jacek Kot, Ewa Lenkiewicz
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-97226-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726413900349440
author Aneta Miszewska
Jacek Kot
Ewa Lenkiewicz
author_facet Aneta Miszewska
Jacek Kot
Ewa Lenkiewicz
author_sort Aneta Miszewska
collection DOAJ
description Abstract This study aimed to identify, based on available literature, the risk factors for adverse events during transport and hyperbaric oxygen therapy (HBOT) sessions in intensive care unit patients and to determine their impact on intra-ward mortality and hospitalization duration. A retrospective analysis was conducted on hospitalized intensive care patients requiring HBOT between 2013 and 2023 at the Department of Hyperbaric Medicine and Sea Rescue, University Centre for Maritime and Tropical Medicine in Gdynia, Poland. A total of 176 patients met the inclusion criteria for analysis. The following risk factors for adverse events during transport and HBOT sessions were identified: continuous intravenous infusions of catecholamines and analgo-sedation, nighttime HBOT sessions (56.55% of all sessions), presence of pleural cavity drainage, and mechanical ventilation via an intubation tube. The number of HBOT sessions had a statistically significant effect in reducing the risk of death (RR = 0.71, p < 0.001), while the administration of catecholamines significantly increased the risk of death (RR = 3.56, p = 0.045). Patients with severe infections (NSTI and gas gangrene) are at higher risk of adverse events and mortality. Therefore, every effort should be made to prevent untoward incidents during their HBOT sessions, including transport to the hyperbaric chamber. The first 72 h of hospitalization for critically ill patients receiving HBOT are crucial for intra-ward survival.
format Article
id doaj-art-b0fb65e7019d4535bde7e060995c7e96
institution DOAJ
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-b0fb65e7019d4535bde7e060995c7e962025-08-20T03:10:10ZengNature PortfolioScientific Reports2045-23222025-04-011511710.1038/s41598-025-97226-6Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospitalAneta Miszewska0Jacek Kot1Ewa Lenkiewicz2Division of Medical Rescue, Medical University of GdanskNational Centre for Hyperbaric Medicine, Institute of Maritime and Tropical Medicine, Medical University of GdanskDepartment of Hyperbaric Medicine and Sea Rescue, University Centre for Maritime and Tropical Medicine in GdyniaAbstract This study aimed to identify, based on available literature, the risk factors for adverse events during transport and hyperbaric oxygen therapy (HBOT) sessions in intensive care unit patients and to determine their impact on intra-ward mortality and hospitalization duration. A retrospective analysis was conducted on hospitalized intensive care patients requiring HBOT between 2013 and 2023 at the Department of Hyperbaric Medicine and Sea Rescue, University Centre for Maritime and Tropical Medicine in Gdynia, Poland. A total of 176 patients met the inclusion criteria for analysis. The following risk factors for adverse events during transport and HBOT sessions were identified: continuous intravenous infusions of catecholamines and analgo-sedation, nighttime HBOT sessions (56.55% of all sessions), presence of pleural cavity drainage, and mechanical ventilation via an intubation tube. The number of HBOT sessions had a statistically significant effect in reducing the risk of death (RR = 0.71, p < 0.001), while the administration of catecholamines significantly increased the risk of death (RR = 3.56, p = 0.045). Patients with severe infections (NSTI and gas gangrene) are at higher risk of adverse events and mortality. Therefore, every effort should be made to prevent untoward incidents during their HBOT sessions, including transport to the hyperbaric chamber. The first 72 h of hospitalization for critically ill patients receiving HBOT are crucial for intra-ward survival.https://doi.org/10.1038/s41598-025-97226-6Hyperbaric oxygen therapyIntensive care medicineRiskSafety
spellingShingle Aneta Miszewska
Jacek Kot
Ewa Lenkiewicz
Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
Scientific Reports
Hyperbaric oxygen therapy
Intensive care medicine
Risk
Safety
title Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
title_full Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
title_fullStr Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
title_full_unstemmed Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
title_short Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
title_sort safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital
topic Hyperbaric oxygen therapy
Intensive care medicine
Risk
Safety
url https://doi.org/10.1038/s41598-025-97226-6
work_keys_str_mv AT anetamiszewska safetyofintensivecarehyperbaricoxygentherapysessionsatatertiaryacademichospital
AT jacekkot safetyofintensivecarehyperbaricoxygentherapysessionsatatertiaryacademichospital
AT ewalenkiewicz safetyofintensivecarehyperbaricoxygentherapysessionsatatertiaryacademichospital